These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 11258145

  • 1. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
    Swislocki AL, Siegel D.
    Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145
    [Abstract] [Full Text] [Related]

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED, Preddie DC.
    Ethn Dis; 2002 Sep; 12(4):S3-49-52. PubMed ID: 12477155
    [Abstract] [Full Text] [Related]

  • 4. Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease.
    Ferrari P.
    Nephrology (Carlton); 2007 Feb; 12(1):81-9. PubMed ID: 17295666
    [Abstract] [Full Text] [Related]

  • 5. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy.
    Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S.
    CMAJ; 2000 Jan 25; 162(2):195-8. PubMed ID: 10674051
    [Abstract] [Full Text] [Related]

  • 6. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment.
    Elliott HL.
    Blood Press Suppl; 1994 Jan 25; 2():31-4. PubMed ID: 8061843
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin-converting enzyme inhibition in renal disease; contrasting effects on renal function in renal artery stenosis and progressive renal injury.
    Jackson B, Johnston CI.
    J Hum Hypertens; 1989 Jun 25; 3 Suppl 1():107-15. PubMed ID: 2674436
    [Abstract] [Full Text] [Related]

  • 8. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 25; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in newly diagnosed type 2 diabetes in Germany.
    Adarkwah CC, Gandjour A.
    Int J Technol Assess Health Care; 2010 Jan 25; 26(1):62-70. PubMed ID: 20059782
    [Abstract] [Full Text] [Related]

  • 10. Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model.
    Campbell HM, Boardman KD, Dodd MA, Raisch DW.
    Ann Pharmacother; 2007 Jul 25; 41(7):1101-10. PubMed ID: 17609233
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Kjeldsen SE, Julius S.
    Am Heart J; 2004 Nov 25; 148(5):747-54. PubMed ID: 15523303
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S, Perna A, Hiddema W, Ruggenenti P, Remuzzi G, Navis G, Postma MJ.
    Pharmacogenet Genomics; 2009 Sep 25; 19(9):695-703. PubMed ID: 19696696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.